Top Biotech Stocks Rallied are DNDN, CRXX, LJPC, XOMA, INSM, QCOR

Dendreon Corporation (NASDAQ:DNDN) climbed up 6.83% over its previous day’s price and now trades at $34.76.  The stock today also touched a new 52 week high at $35.27.  Dendreon Corporation (Dendreon) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that may improve cancer treatment options for patients.

Subscribe to daily free stock newsletter by visiting:  http://www.pennystockpickreport.com/

CombinatoRx, Incorporated (NASDAQ:CRXX) jumped 41.44% to $1.57 on an unusual high volume of 17.72 million shares. The stock has a 52-week range of $0.41-$2.60. The company today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Exalgo™ (hydromorphone HCl) extended-release tablets, for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.

La Jolla Pharmaceutical Company (NASDAQ:LJPC) soared 53.36% over its previous day’s price and now trades at $0.187 on an unusual high volume of 17.72 million shares. The stock has a 52-week range of $0.04-$0.64. La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the development and testing of Riquent as a treatment for Lupus nephritis. Lupus is an antibody-mediated disease caused by abnormal B cell production of antibodies that attack healthy tissues. The Company’s wholly owned subsidiary is La Jolla Limited.

XOMA Limited (NASDAQ:XOMA) zoomed 8.14% to $0.530. The stock has a 52-week range of $0.37-$1.34. XOMA Ltd. is a biopharmaceutical company focused on the discovery, development and manufacture of therapeutic antibodies. XOMA uses its expertise, technologies and capabilities to build a product pipeline that includes multiple collaborative development programs.

Insmed Incorporated (NASDAQ:INSM) rallied 12.15% to $1.20 on an unusual high volume of 3.02 million shares The stock has a 52-week range of $0.70-$2.57. Insmed Incorporated (Insmed) is a development stage biopharmaceutical company specializing in recombinant protein drug development. The Company also engaged the services of RBC to act as financial advisor. On March 31, 2009, the Company completed the sale of its follow-on biologics assets to Merck & Co., Inc. (Merck).

Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) surged 15.87% over its previous day’s price and now trades at $5.55 on an unusual high volume of 1.93 million shares. The stock has a 52-week range of $3.10-$6.79. The company reported financial results for the fourth quarter and year ended December 31, 2009.  Net sales totaled $25.9 million for the quarter ended December 31, 2009 compared to $13.9 million for the quarter ended September 30, 2009, and $27.0 million for the fourth quarter of 2008.  Net income for the fourth quarter of 2009 was $8.4 million, or $0.13 per diluted common share compared to $1.2 million, or $0.02 per diluted common share for the third quarter of 2009, and $16.2 million, or $0.24 per diluted common share for the fourth quarter of 2008.  Net sales totaled $88.3 million for the year ended December 31, 2009, compared with $95.2 million for 2008. Net income for 2009 was $26.6 million, or $0.40 per diluted common share compared with net income applicable to common shareholders of $35.3 million, or $0.49 per diluted common share for 2008.

About http://www.pennystockpickreport.com/

Penny Stock Pick Report offers a stock newsletter on OTC, PINKSHEETS ,OTCBB, AMEX, NASDAQ and NYSE stock exchange. Our subscribers receive daily up to date stock information on hot stocks ,most active movers, top gainers, penny stocks and much more. If you wish to feature your organization on our website then you can contact us at the email given below.